In thyroid cancer cells, miR-200b/c inhibits the activity of the NF-κB/Twist-1 pathway and suppresses cell migration and invasion by reducing RAP1B levels [39]. This evidence concerns the gene NFKB1 and thyroid gland carcinoma.